Tag: PSA

In September, 2018 we posted a blog on this promising news of the IsoPSA blood test for prostate cancer (PCa). Then, in October 2019, the FDA granted breakthrough device designation to the test, in order to work closely with the manufacturer to expedite approval. This move sprang from... keep reading

When it comes to spending money, you have choices. According to wealthfit.com, “Whether you spend 10 seconds or 10 days weighing a decision, each one comes with strings attached. With each option you choose, you’re saying ‘no’ to a different option. The value of what you do not select is called your opportunity cost. You keep reading

I have written in the past about the problems with using prostate specific antigen (PSA) as a screening tool for prostate cancer. Virtually all men over age 40 know they should have a PSA blood test at their annual exam, yet few have a complete understanding of what it really says... keep reading

Word is spreading fast that a dietary supplement called 4-MU can stop prostate cancer (PCa) in its tracks. Stories like Fox News Health’s “Dietary Supplement May Prevent and Treat Prostate Cancer, Study Says,” and the bulletin from the... keep reading

In one sense, the greatest cure for cancer is to keep it from happening in the first place. Your local drugstore may be the source of inexpensive products that help protect men against prostate cancer such as... keep reading

If a college student plans to go on for a higher degree after graduation, grade point average (GPA) can make a difference in being accepted into grad programs. A perfect 4.0 GPA is desirable. A+, A and A- all have the same 4-point equivalence, so what’s the point of adding a plus or minus sign? keep reading

Good news! The widespread integration of multiparametric MRI (mpMRI) and MRI-guided targeted biopsies has resulted in both better initial qualification of AS candidates, and significantly better ability to monitor for significant PCa by PSA + mpMRI. As a side benefit... keep reading

The FDA-approved PCA3 urine test (Progensa) for detecting a biomarker that is overexpressed in prostate cancer (PCa) was acknowledged by the American Urological Association as far back as 2013 as a useful adjunct – along with other PSA derivatives – for determining if a biopsy or repeat biopsy was needed. keep reading

Baseball fans are familiar with the Baltimore Orioles, a team named for the state bird of Maryland. Since 1954, the bird has brought them luck: 7 pennants and 3 World Series. Now there’s a new ORIOLE that’s having a winning season in the fight against metastatic prostate cancer. ORIOLE stands for a study called the keep reading

Is there any human being who would greet a cancer diagnosis with good cheer? I suspect not, because it’s not good news. It automatically triggers the most basic of all fears: am I going to die? Even the most optimistic or logical person can’t keep that question from popping up, at least momentarily. If the keep reading